Solid Biosciences (SLDB) PT Raised to $26 at Cantor Fitzgerald Before INSPIRE Ph1/2 Readout

August 27, 2026 7:30 AM

Cantor Fitzgerald analyst Kristen Kluska raised the price target on Solid Biosciences (NASDAQ: SLDB) to $26.00 (from $16.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found